In fact, obesity was demonstrated to be a positive regulator of IL-6 and IL-6 receptor levels in subcutaneous WAT, which contributed to induction of inflammation and obesity-associated metabolic dysfunctions in mice [80]. The gene discussed is IL6; the disease is obesity disorder.